News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive. The post Why Pharma Must Rethink How It Explains the Vaccine Schedule—Not Just Defend It appeared first on maslansky+partners.
